Fred Alger Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $594K | Sell |
18,271
-4,089
| -18% | -$133K | ﹤0.01% | 380 |
|
|
2025
Q1 | $844K | Sell |
22,360
-500,647
| -96% | -$18.9M | ﹤0.01% | 335 |
|
|
2024
Q4 | $42.8M | Sell |
523,007
-720,710
| -58% | -$59M | 0.2% | 77 |
|
|
2024
Q3 | $142M | Sell |
1,243,717
-66,719
| -5% | -$7.62M | 0.69% | 30 |
|
|
2024
Q2 | $99M | Sell |
1,310,436
-86,275
| -6% | -$6.51M | 0.48% | 45 |
|
|
2024
Q1 | $95.4M | Sell |
1,396,711
-273,478
| -16% | -$18.7M | 0.47% | 44 |
|
|
2023
Q4 | $105M | Sell |
1,670,189
-423,116
| -20% | -$26.6M | 0.57% | 44 |
|
|
2023
Q3 | $107M | Sell |
2,093,305
-277,913
| -12% | -$14.2M | 0.61% | 38 |
|
|
2023
Q2 | $118M | Buy |
2,371,218
+1,526,440
| +181% | +$76.2M | 0.6% | 37 |
|
|
2023
Q1 | $31.7M | Sell |
844,778
-32,515
| -4% | -$1.22M | 0.17% | 137 |
|
|
2022
Q4 | $42.1M | Buy |
+877,293
| New | +$42.1M | 0.23% | 127 |
|
|
2022
Q2 | – | Sell |
-9,677
| Closed | -$234K | – | 538 |
|
|
2022
Q1 | $234K | Buy |
+9,677
| New | +$234K | ﹤0.01% | 434 |
|